387 related articles for article (PubMed ID: 31976601)
1. Regulation of bile acid metabolism in biliary atresia: reduction of FGF19 by Kasai portoenterostomy and possible relation to early outcome.
Johansson H; Svensson JF; Almström M; Van Hul N; Rudling M; Angelin B; Nowak G; Fischler B; Ellis E
J Intern Med; 2020 May; 287(5):534-545. PubMed ID: 31976601
[TBL] [Abstract][Full Text] [Related]
2. Serum FGF19 predicts outcomes of Kasai portoenterostomy in biliary atresia.
Nyholm I; Hukkinen M; Pihlajoki M; Davidson JR; Tyraskis A; Lohi J; Heikkilä P; Hänninen S; Andersson N; Eloranta K; Carpén O; Heikinheimo M; Davenport M; Pakarinen MP
Hepatology; 2023 Apr; 77(4):1263-1273. PubMed ID: 36692476
[TBL] [Abstract][Full Text] [Related]
3. Ileal bile acid transporter inhibition as an anticholestatic therapeutic target in biliary atresia and other cholestatic disorders.
Karpen SJ; Kelly D; Mack C; Stein P
Hepatol Int; 2020 Sep; 14(5):677-689. PubMed ID: 32653991
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte growth factor levels in livers and serum at Kasai-portoenterostomy are not predictive of clinical outcome in infants with biliary atresia.
Madadi-Sanjani O; Kuebler JF; Dippel S; Gigina A; Falk CS; Vieten G; Petersen C; Klemann C
Growth Factors; 2019 Apr; 37(1-2):68-75. PubMed ID: 31185750
[TBL] [Abstract][Full Text] [Related]
5. Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosis.
Li Z; Lin B; Lin G; Wu Y; Jie Y; Li X; Ko B; Chong Y; Luo J
PLoS One; 2017; 12(6):e0178580. PubMed ID: 28570655
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of Circulating FGF19 and Bile Acids in Primary Biliary Cholangitis-Autoimmune Hepatitis Overlap Syndrome.
Li Z; Liu Y; Yang F; Pang J; Wu Y; Chong Y; Li X
Biomed Res Int; 2020; 2020():1934541. PubMed ID: 32626734
[TBL] [Abstract][Full Text] [Related]
7. Asynchronous rhythms of circulating conjugated and unconjugated bile acids in the modulation of human metabolism.
Al-Khaifi A; Straniero S; Voronova V; Chernikova D; Sokolov V; Kumar C; Angelin B; Rudling M
J Intern Med; 2018 Nov; 284(5):546-559. PubMed ID: 29964306
[TBL] [Abstract][Full Text] [Related]
8. Developmental regulation of the gut-liver (FGF19-CYP7A1) axis in neonates.
Memon N; Griffin IJ; Lee CW; Herdt A; Weinberger BI; Hegyi T; Carayannopoulos MO; Aleksunes LM; Guo GL
J Matern Fetal Neonatal Med; 2020 Mar; 33(6):987-992. PubMed ID: 30122083
[No Abstract] [Full Text] [Related]
9. Expression of hepatic Fibroblast Growth Factor 19 is enhanced in Primary Biliary Cirrhosis and correlates with severity of the disease.
Wunsch E; Milkiewicz M; Wasik U; Trottier J; Kempińska-Podhorodecka A; Elias E; Barbier O; Milkiewicz P
Sci Rep; 2015 Aug; 5():13462. PubMed ID: 26293907
[TBL] [Abstract][Full Text] [Related]
10. Vitamin A can ameliorate fibrosis of liver in an established rat model of biliary atresia and Kasai portoenterostomy.
Yeh YT; Lin NC; Yeh YC; Tsai HL; Chen CY; Liu CP; Liu C
J Pediatr Surg; 2018 Dec; 53(12):2416-2422. PubMed ID: 30257812
[TBL] [Abstract][Full Text] [Related]
11. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man.
Lundåsen T; Gälman C; Angelin B; Rudling M
J Intern Med; 2006 Dec; 260(6):530-6. PubMed ID: 17116003
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome and necessity of liver transplantation in infants with biliary atresia are independent of cytokine milieu in native liver and serum.
Madadi-Sanjani O; Kuebler JF; Dippel S; Gigina A; Falk CS; Vieten G; Petersen C; Klemann C
Cytokine; 2018 Nov; 111():382-388. PubMed ID: 30300856
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant steroid treatment following Kasai portoenterostomy and clinical outcomes of biliary atresia patients: an updated meta-analysis.
Zhang MZ; Xun PC; He K; Cai W
World J Pediatr; 2017 Feb; 13(1):20-26. PubMed ID: 27830578
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota Composition of Biliary Atresia Patients Before Kasai Portoenterostomy Associates With Long-term Outcome.
van Wessel D; Nomden M; Bruggink J; de Kleine R; Kurilshikov A; Verkade H; Harmsen H; Hulscher J
J Pediatr Gastroenterol Nutr; 2021 Oct; 73(4):485-490. PubMed ID: 34269330
[TBL] [Abstract][Full Text] [Related]
15. A nontumorigenic variant of FGF19 treats cholestatic liver diseases.
Luo J; Ko B; Elliott M; Zhou M; Lindhout DA; Phung V; To C; Learned RM; Tian H; DePaoli AM; Ling L
Sci Transl Med; 2014 Jul; 6(247):247ra100. PubMed ID: 25080475
[TBL] [Abstract][Full Text] [Related]
16. High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis.
Schaap FG; van der Gaag NA; Gouma DJ; Jansen PL
Hepatology; 2009 Apr; 49(4):1228-35. PubMed ID: 19185005
[TBL] [Abstract][Full Text] [Related]
17. Surgical modifications of the Kasai hepatoportoenterostomy minimize invasiveness without compromising short- and medium-term outcomes.
Park CJ; Armenia SJ; Keung CH; Compton JT; Cowles RA
J Pediatr Surg; 2019 Mar; 54(3):537-542. PubMed ID: 30041859
[TBL] [Abstract][Full Text] [Related]
18. Deep learning quantification reveals a fundamental prognostic role for ductular reaction in biliary atresia.
Nyholm I; Sjöblom N; Pihlajoki M; Hukkinen M; Lohi J; Heikkilä P; Mutka A; Jahnukainen T; Davenport M; Heikinheimo M; Arola J; Pakarinen MP
Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38051554
[TBL] [Abstract][Full Text] [Related]
19. Five-year native liver survival analysis in biliary atresia from a single large Chinese center: The death/liver transplantation hazard change and the importance of rapid early clearance of jaundice.
Wang Z; Chen Y; Peng C; Pang W; Zhang T; Wu D; Shen Q; Li M
J Pediatr Surg; 2019 Aug; 54(8):1680-1685. PubMed ID: 30518490
[TBL] [Abstract][Full Text] [Related]
20. New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study.
Uriarte I; Santamaria E; López-Pascual A; Monte MJ; Argemí J; Latasa MU; Adán-Villaescusa E; Irigaray A; Herranz JM; Arechederra M; Basualdo J; Lucena F; Corrales FJ; Rotellar F; Pardo F; Merlen G; Rainteau D; Sangro B; Tordjmann T; Berasain C; Marín JJG; Fernández-Barrena MG; Herrero I; Avila MA
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167166. PubMed ID: 38642480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
